College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Department of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou 730050, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Feb 5;53(1):116-125. doi: 10.3724/zdxbyxb-2023-0233.
To prepare 7-hydroxyethyl chrysin (7-HEC) loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles and to detect the release.
The 7-HEC/PLGA nanoparticles were prepared by emulsification solvent volatilization method. The particle size, polydispersity index (PDI), encapsulation rate, drug loading and zeta potential were measured. The prescription was optimized by single factor investigation combined with Box-Behnken response surface method. Mannitol was used as protectant to prepare lyophilized powder, and the optimal formulation was characterized and studied for the release.
The optimal formulation of 7-HEC/PLGA nanoparticles was as follows: drug loading ratio of 2.12∶20, oil-water volume ratio of 1∶14.7, and 2.72% soybean phospholipid as emulsifier. With the optimal formulation, the average particle size of 7-HEC/PLGA nanoparticles was (240.28±0.96) nm, the PDI was 0.25±0.69, the encapsulation rate was (75.74±0.80)%, the drug loading capacity was (6.98±0.83)%, and the potentiostatic potential was (-18.17±0.17) mV. The cumulative release reached more than 50% within 48 h.
The optimized formulation is stable and easy to operate. The prepared 7-HEC/PLGA nanoparticles have uniform particle size, high encapsulation rate and significantly higher dissolution rate than 7-HEC.
制备 7-羟乙基白杨素(7-HEC)负载的聚乳酸-共-羟基乙酸(PLGA)纳米粒并检测其释放情况。
采用乳化溶剂挥发法制备 7-HEC/PLGA 纳米粒。测定纳米粒的粒径、多分散指数(PDI)、包封率、载药量和 Zeta 电位。采用单因素考察结合 Box-Behnken 响应面法优化处方。甘露醇作为保护剂制备冻干粉末,对优化处方进行表征并研究其释放情况。
7-HEC/PLGA 纳米粒的最佳处方为:载药比 2.12∶20、油水比 1∶14.7、大豆磷脂用量 2.72%。在此最佳处方下,7-HEC/PLGA 纳米粒的平均粒径为(240.28±0.96)nm,PDI 为 0.25±0.69,包封率为(75.74±0.80)%,载药量为(6.98±0.83)%,Zeta 电位为(-18.17±0.17)mV。48 h 内累积释放率超过 50%。
优化处方稳定,操作简便。所制备的 7-HEC/PLGA 纳米粒粒径均一,包封率高,溶出速率明显高于 7-HEC。